Stockreport

Daxor Corporation Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market

Daxor Corporation - Closed End Fund  (DXR) 
NASDAQ:AMEX Investor Relations: daxor.com/investors
PDF NEW YORK, March 03, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumen [Read more]